Cargando…
Pembrolizumab induced pericardial tamponade: A case report
KEY CLINICAL MESSAGE: The occurrence of a large pericardial effusion is not a commonly noted adverse event associated with pembrolizumab and our report demonstrates that a rapid development can be diagnosed with close monitoring and triage to acute medical settings. ABSTRACT: Pembrolizumab is an imm...
Autores principales: | Uczkowski, Dariusz, Ashraf, Hamza, Sekhri, Arunabh, Samad, Arbaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152068/ https://www.ncbi.nlm.nih.gov/pubmed/37143451 http://dx.doi.org/10.1002/ccr3.7298 |
Ejemplares similares
-
COVID-19 vaccine (Ad26.COV2.S), an unlikely culprit of portal vein thrombosis in a middle-aged man
por: Uczkowski, Dariusz, et al.
Publicado: (2022) -
Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature
por: Harada, Kazuaki, et al.
Publicado: (2020) -
Lysozyme‐induced nephropathy due to systemic granulomatous disease
por: Ashraf, Hamza, et al.
Publicado: (2023) -
Pericardial tamponade due to haemorrhagic pericardial effusion as a complication of prasugrel: a case report
por: Cader, Fathima Aaysha, et al.
Publicado: (2016) -
Adalimumab: Disseminated Mycobacterium tuberculous pericardial tamponade: case report
Publicado: (2021)